BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Art Pappas joins a Venture Capital Panel at BioContactQuébec 2012 on October 3 in Quebec City.
News | 08. 14. 2012
Art Pappas joins a Venture Capital Panel at BioContactQuébec 2012 on October 3 in Quebec City.
